Building on Areas of Mutual Interest
At Inspire, we are intent on providing medicines that make a difference in patients' lives. We are interested in partnerships that balance our product portfolio, complementing the line of products from our own internal research efforts and augmenting our core therapeutic areas of Ophthalmology and Respiratory/Allergy. Of particular interest are:

Focused Therapeutic Areas
  Ophthalmology
  Respiratory/Allergy

Highest Priorities
  Allergic Disease
  Cystic Fibrosis
  Glaucoma
  Ocular Surface Disease

Technology Platforms

  Latrunculin B
  Purinergic Receptor Agonists and Antagonists
  Rho Kinase Inhibitors

For in-licensing candidates, we are seeking compounds or products that provide a meaningful benefit over currently existing treatments either through novel mechanism of action, unique delivery mechanism, improved efficacy, safety, quality of life or other significant feature. We are particularly interested in therapies for specialty therapeutic markets.

We are seeking out-licensing partners for our cystic fibrosis and glaucoma programs for markets outside of North America.

 



 

 

 

 

Page last updated: 03-Jan-2008

Copyright © 1999-2005 Inspire Pharmaceuticals Inc. All rights reserved